FNY Managed Accounts LLC Acquires Shares of 1,000 Zimmer Biomet Holdings, Inc. (ZBH)

FNY Managed Accounts LLC acquired a new position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 1,000 shares of the medical equipment provider’s stock, valued at approximately $117,000.

A number of other hedge funds also recently added to or reduced their stakes in the business. Great West Life Assurance Co. Can raised its holdings in Zimmer Biomet by 3.4% during the third quarter. Great West Life Assurance Co. Can now owns 148,201 shares of the medical equipment provider’s stock worth $17,118,000 after purchasing an additional 4,908 shares in the last quarter. Nordea Investment Management AB raised its holdings in Zimmer Biomet by 7.3% during the third quarter. Nordea Investment Management AB now owns 5,277,660 shares of the medical equipment provider’s stock worth $617,961,000 after purchasing an additional 357,302 shares in the last quarter. Van ECK Associates Corp increased its holdings in shares of Zimmer Biomet by 7.8% in the 3rd quarter. Van ECK Associates Corp now owns 264,597 shares of the medical equipment provider’s stock valued at $30,982,000 after acquiring an additional 19,081 shares during the period. Oppenheimer & Co. Inc. increased its holdings in shares of Zimmer Biomet by 12.3% in the 3rd quarter. Oppenheimer & Co. Inc. now owns 36,040 shares of the medical equipment provider’s stock valued at $4,220,000 after acquiring an additional 3,954 shares during the period. Finally, Sivik Global Healthcare LLC acquired a new position in shares of Zimmer Biomet in the 3rd quarter valued at $2,927,000. 85.36% of the stock is currently owned by institutional investors.

A number of equities analysts have recently commented on the stock. Zacks Investment Research cut shares of Zimmer Biomet from a “hold” rating to a “strong sell” rating in a report on Monday, November 20th. Deutsche Bank AG raised shares of Zimmer Biomet from a “hold” rating to a “buy” rating and set a $128.00 target price on the stock in a report on Tuesday, November 14th. Edward Jones raised shares of Zimmer Biomet from a “hold” rating to a “buy” rating in a report on Thursday, November 9th. Royal Bank Of Canada cut their target price on shares of Zimmer Biomet to $125.00 and set an “outperform” rating on the stock in a report on Tuesday, November 7th. Finally, Stifel Nicolaus reaffirmed a “hold” rating and issued a $120.00 target price on shares of Zimmer Biomet in a report on Friday, November 3rd. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company. Zimmer Biomet currently has an average rating of “Hold” and an average target price of $133.71.

Shares of Zimmer Biomet Holdings, Inc. (ZBH) remained flat at $$113.07 on Monday. 289,000 shares of the company’s stock were exchanged, compared to its average volume of 1,354,421. The company has a current ratio of 1.47, a quick ratio of 0.78 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $22,890.00, a price-to-earnings ratio of 14.01, a PEG ratio of 1.76 and a beta of 1.17. Zimmer Biomet Holdings, Inc. has a 52-week low of $99.11 and a 52-week high of $133.49.

Zimmer Biomet (NYSE:ZBH) last announced its quarterly earnings data on Wednesday, November 1st. The medical equipment provider reported $1.72 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.74 by ($0.02). The firm had revenue of $1.82 billion during the quarter, compared to analyst estimates of $1.83 billion. Zimmer Biomet had a net margin of 8.36% and a return on equity of 16.29%. The business’s quarterly revenue was down .8% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.79 earnings per share. sell-side analysts forecast that Zimmer Biomet Holdings, Inc. will post 8.03 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “FNY Managed Accounts LLC Acquires Shares of 1,000 Zimmer Biomet Holdings, Inc. (ZBH)” was published by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this story on another domain, it was copied illegally and republished in violation of United States and international copyright laws. The legal version of this story can be viewed at https://transcriptdaily.com/2017/11/27/fny-managed-accounts-llc-acquires-shares-of-1000-zimmer-biomet-holdings-inc-zbh.html.

About Zimmer Biomet

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply